Xenetic Biosciences (XBIO) Research & Development (2014 - 2026)
Xenetic Biosciences' Research & Development came in at $552,013 for Q2 2026, down 15.9% from $656,557 a year earlier and down 16.5% from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) Research & Development (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Xenetic Biosciences reported Research & Development of $2.74 million, down 6.9% year-over-year; for FY2025, it was $3.07 million, down 6.8% from FY2024.
- Research & Development has declined in each of the last three years, though with a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
- Going back by year, Research & Development was $3.29 million in FY2024 (-5.9%), $3.49 million in FY2023 (-26.7%), $4.77 million in FY2022 (+50.8%) and $3.16 million in FY2021 (+82.7%).
- The Q2 2026 figure represents the lowest quarterly Research & Development since Q3 2024.
- Year-over-year, Research & Development has declined for three consecutive quarters, with an average decline of 6.8% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q2 2022 (growth of 296.1%), and the weakest in Q3 2024 (a decline of 63.9%).
- Business Quant data shows XBIO's Research & Development at $661,443 (Q1 2026), $773,416 (Q4 2025) and $756,482 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Xenetic Biosciences | 4.52 Mn | -21.30 Mn | - | 552,013.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 552,013.00 |
| Mar 31, 2026 | 661,443.00 |
| Dec 31, 2025 | 773,416.00 |
| Sep 30, 2025 | 756,482.00 |
| Jun 30, 2025 | 656,557.00 |
| Mar 31, 2025 | 879,029.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 367,985.00 |
| Jun 30, 2024 | 933,771.00 |
| Mar 31, 2024 | 944,321.00 |
| Dec 31, 2023 | 975,628.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 903,243.00 |
| Mar 31, 2023 | 595,276.00 |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 398,803.00 |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 780,153.00 |
API Access
Xenetic Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();